An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen
Molecular Therapy: Nucleic Acids
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen. // Molecular Therapy: Nucleic Acids. – URL: https://www.sciencedirect.com/science/article/pii/S2162253126002544?dgcid=rss_sd_all
An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen. Molecular Therapy: Nucleic Acids. https://www.sciencedirect.com/science/article/pii/S2162253126002544?dgcid=rss_sd_all
“An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen.” Molecular Therapy: Nucleic Acids.
@article{article59487,
title = {An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen},
journal = {Molecular Therapy: Nucleic Acids},
url = {https://www.sciencedirect.com/science/article/pii/S2162253126002544?dgcid=rss_sd_all}
}